Pain. Pain, unspecified
Conditions
Interventions
Intervention 1: 2 week later (washout) , same patients receive aromatherapy intervention. three drops of aromatherapy blend containing Lavender essence 10% were poured on cotton in cast containers,
and pain severity of venepuncture measure and record using the VAS . this intervention also conduct in the three consecutive dialysis sessions. Intervention 2: one week later ,all patients receive
Treatment - Drugs
Diagnosis
2 week later (washout) , same patients receive aromatherapy intervention. three drops of aromatherapy blend containing Lavender essence 10% were poured on cotton in cast containers, and the patient
and pain severity of venepuncture measure and record using the VAS . this intervention also conduct in the three consecutive dialysis sessions.
one week later ,all patients receive lidocaine2% gel 15-20min before AVF puncture in area of 5cm2 at the designated site. No cover is placing at the designated site then gel remove and the skin di
First patients complete a demographic questionnaire and pain visual analog scale and based on inclusion criteria entere into the study and pain intensity evaluate and record by patients immediately a
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 18 yr of age or older; be conscious; non smoking; lake of damaged; denuded, or broken skin at the designated site; lake of known allergies or sensitivities to lidocaine, prilocaine or other local anesthetic; no sensitivities to lavender aromatherapy; non used of alcohol and opioid substances; have a good sense of smell; minimum of reading and writing; no history of mental disorders. Exclusion criteria: afflict severe cold or non have a healthy sense of smell; concomitant use of an analgesic within the previous 24 h; or previous use of lidocaine/ prilocaine cream; extend the time interval over 1 hour of drug administration; patient's unwillingness to continue the study; the patient died.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: berore intervention and after every intervention. Method of measurement: Visual analoug scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReyhaneh Abbaszadeh
Tehran University of Medical Sciences
Outcome results
None listed